GoodRx (GDRX) Stock Chart & Stock Price History → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free GDRX Stock Alerts $6.60 -0.33 (-4.76%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media GoodRx Stock Price Performance5 Day Performance-7.04%1 Month Performance-5.71%3 Month Performance+1.38%6 Month Performance+37.79%Year-To-Date Performance-1.49%1 Year Performance+37.50% Receive GDRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him GDRX Stock Chart for Friday, May, 10, 2024 GDRX Chart by TradingView GoodRx Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$7.61$6.93-8.94%$7.35$6.754.19 million shs$2.74 billion05/08/2024$7.53$7.61+1.06%$7.68$7.353.47 million shs$3.01 billion05/07/2024$7.47$7.53+0.80%$7.69$7.311.72 million shs$2.97 billion05/06/2024$7.10$7.47+5.21%$7.48$7.211.04 million shs$2.95 billion05/03/2024$7.01$7.10+1.28%$7.26$7.00551,275 shs$2.80 billion05/02/2024$6.97$7.01+0.57%$7.09$6.79723,105 shs$2.77 billion Get the Latest News and Ratings for GDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$7.10$6.97-1.83%$7.17$6.91723,658 shs$2.75 billion04/30/2024$7.15$7.10-0.70%$7.16$7.01686,765 shs$2.80 billion04/29/2024$7.19$7.15-0.56%$7.25$7.06515,381 shs$2.82 billion04/26/2024$7.08$7.19+1.55%$7.35$7.10934,509 shs$2.84 billion04/25/2024$6.96$7.08+1.72%$7.09$6.81558,378 shs$2.80 billion04/24/2024$6.97$6.96-0.14%$7.13$6.84608,872 shs$2.75 billion04/23/2024$6.66$6.97+4.65%$7.03$6.521.11 million shs$2.75 billion04/22/2024$6.69$6.66-0.45%$6.73$6.57404,235 shs$2.63 billion04/19/2024$6.73$6.69-0.59%$6.74$6.60643,983 shs$2.64 billion04/18/2024$6.50$6.73+3.54%$6.77$6.50591,168 shs$2.66 billion04/17/2024$6.52$6.50-0.31%$6.75$6.46973,504 shs$2.57 billion04/16/2024$6.55$6.52-0.46%$6.76$6.441.28 million shs$2.58 billion04/15/2024$6.83$6.55-4.10%$6.82$6.461.27 million shs$2.59 billion04/12/2024$6.92$6.83-1.30%$6.91$6.80530,393 shs$2.70 billion04/11/2024$7.00$6.92-1.14%$7.03$6.70963,068 shs$2.73 billion04/10/2024$6.74$7.00+3.86%$7.05$6.741.54 million shs$2.77 billion04/09/2024$6.84$6.74-1.46%$7.12$6.69859,380 shs$2.66 billion04/08/2024$6.90$6.84-0.87%$7.02$6.83607,842 shs$2.70 billion04/05/2024$6.71$6.90+2.83%$6.90$6.61836,193 shs$2.73 billion04/04/2024$6.72$6.71-0.15%$6.85$6.65801,989 shs$2.65 billion04/03/2024$6.80$6.72-1.18%$6.83$6.691.32 million shs$2.65 billion04/02/2024$7.10$6.80-4.23%$6.96$6.701.10 million shs$2.69 billion04/01/2024$7.10$7.10$7.19$6.95854,594 shs$2.80 billion03/29/2024$7.10$7.10$7.28$7.031.17 million shs$2.80 billion03/28/2024$7.01$7.10+1.28%$7.28$7.031.17 million shs$2.80 billion03/27/2024$7.06$7.01-0.71%$7.23$6.911.24 million shs$2.77 billion03/26/2024$7.07$7.06-0.14%$7.48$6.971.39 million shs$2.79 billion03/25/2024$6.58$7.07+7.45%$7.93$7.052.62 million shs$2.79 billion03/22/2024$6.75$6.58-2.52%$6.77$6.58460,143 shs$2.60 billion03/21/2024$6.80$6.75-0.74%$6.95$6.72966,438 shs$2.67 billion03/20/2024$6.55$6.80+3.82%$6.88$6.44775,504 shs$2.69 billion03/19/2024$6.57$6.55-0.30%$6.74$6.411.08 million shs$2.59 billion03/18/2024$6.91$6.57-4.92%$7.10$6.541.00 million shs$2.60 billion03/15/2024$6.77$6.91+2.07%$7.03$6.701.55 million shs$2.73 billionRSVP: Charles Payne’s Cash Flow Workshop (Ad)Are you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.Register For Free Now!03/14/2024$7.14$6.77-5.18%$7.10$6.651.30 million shs$2.67 billion03/13/2024$7.22$7.14-1.11%$7.39$7.13800,286 shs$2.82 billion03/12/2024$7.35$7.22-1.77%$7.45$7.191.53 million shs$2.85 billion03/11/2024$7.39$7.35-0.54%$7.47$7.271.28 million shs$2.90 billion03/08/2024$7.54$7.39-1.99%$7.70$7.221.79 million shs$2.92 billion03/07/2024$7.57$7.54-0.40%$7.87$7.501.24 million shs$3.06 billion03/06/2024$7.61$7.57-0.53%$7.73$7.401.10 million shs$3.07 billion03/05/2024$8.08$7.61-5.82%$8.14$7.471.64 million shs$3.09 billion03/04/2024$8.35$8.08-3.23%$8.29$7.753.26 million shs$3.28 billion03/01/2024$7.79$8.35+7.19%$8.52$8.023.88 million shs$3.39 billion02/29/2024$6.47$7.79+20.40%$8.00$7.078.63 million shs$3.16 billion02/28/2024$6.59$6.47-1.82%$6.96$6.384.13 million shs$2.63 billion02/27/2024$6.54$6.59+0.76%$6.68$6.49973,242 shs$2.68 billion02/26/2024$6.38$6.54+2.51%$6.68$6.411.39 million shs$2.66 billion02/23/2024$6.54$6.38-2.45%$6.57$6.301.41 million shs$2.59 billion02/22/2024$6.54$6.54$6.64$6.441.48 million shs$2.66 billion02/21/2024$6.43$6.54+1.71%$6.58$6.271.54 million shs$2.66 billion02/20/2024$6.45$6.43-0.31%$6.49$6.25762,634 shs$2.61 billion02/19/2024$6.45$6.45$6.64$6.44538,000 shs$2.62 billion02/16/2024$6.73$6.45-4.16%$6.64$6.44537,569 shs$2.62 billion02/15/2024$6.62$6.73+1.66%$6.76$6.56657,477 shs$2.73 billion02/14/2024$6.39$6.62+3.60%$6.63$6.341.01 million shs$2.69 billion02/13/2024$6.63$6.39-3.62%$6.50$6.15776,262 shs$2.60 billion02/12/2024$6.51$6.63+1.84%$6.88$6.481.48 million shs$2.69 billion02/09/2024$6.53$6.51-0.31%$6.60$6.46626,053 shs$2.64 billion Related Companies: Arrowhead Pharmaceuticals Stock Chart Summit Therapeutics Stock Chart ACADIA Pharmaceuticals Stock Chart Olink Holding AB (publ) Stock Chart Certara Stock Chart RingCentral Stock Chart PROCEPT BioRobotics Stock Chart QuidelOrtho Stock Chart Life Time Group Stock Chart Azenta Stock Chart Receive GDRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GDRX) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.